Consenso de expertos multidisciplinario para la calidad diagnóstica y uso de biomarcadores en cáncer de pulmón. Asociación Colombiana de Patología (ASOCOLPAT). 2023

• DOI: 10.30789/rcneumologia.v.n..973
• Publication Date: 2024-12-09T21:53:12Z
• Authors: Rafael Parra-Medina; Luz Fernanda Sua; José Fernando Pol...; Ana Margarita Bal...; María Claudia Moreno; Adriana Serna; José Luis Blanco; Luis Fernando Rueda; Juan Carlos Varón...; Alejandra Cañas A...; Liliana Fernández...; Lucía Viola; Darwin Padilla; Stella Isabel Mar...; Ricardo Adolfo Za...; Carlos Alberto Ca...

Introduction: Lung cancer is the third cause of worldwide 2,200,000 and a mortality approximately 35%. Diagnosis by multidisciplinary team has become most effective tool for early treatment. This linked to use immunohistochemistry immunomarkers that in last decade have allowed us strengthen diagnosis involved target-directed therapies. Objective: To define common agreement experts, considerations diagnostic quality biomarkers lung Colombia. Methods: A formal consensus mixed type (Delphi/Nominal), was carried out with participation oncopathologists, pathologists, pulmonologists chest surgeons ASOCOLPAT. group questions answers were graded, which discussed nominal session. The information consolidated Excel analyzed STATA 14. Results: 12 structured rated, addressing following aspects: pathological cancer, description clinical centers, some administrative logistical issues each region Conclusions: experts defined agreement, guidance hoping homogenize both medical aspects order generate an result timely